Objectives: The objective of this study was to systematically review quantitative and qualitative studies on the public's knowledge and beliefs about antibiotic resistance.
Introduction
Antibiotic resistance is a complex problem that transcends international boundaries. It is predicted to kill 10 million people globally each year and cost the global economy US$100 trillion by 2050. 1 Antibiotic use drives resistance 2, 3 and global rates of antibiotic use 4 and resistance 5 continue to rise. However, antibiotic resistance is reversible; resistance in the commensals of individuals who are treated with antibiotics reduces exponentially up to 1 year after the end of antibiotic treatment. 2 Effective actions by all sectors of society to minimize antibiotic resistance through reduced antibiotic use are urgently required, including global taskforces, 1, 6 governments, 7 -9 researchers, 10,11 industry, 11 clinicians and the public. 12, 13 More than 70% of people visiting a primary care practitioner in the USA with an acute respiratory infection receive antibiotics. 14 Systematic reviews demonstrate that antibiotics can provide only minor benefit for these infections, 15 -21 yet half of patients who attend their family physician with an acute respiratory tract infection expect an antibiotic. 22 Public health campaigns in various countries have sought to dispel the myth that antibiotics are necessary for acute respiratory tract infections 23 and several have incorporated messages about antibiotic resistance. 24, 25 To the best of our knowledge, studies of the public's knowledge and beliefs about antibiotic resistance have not been synthesized across studies or settings and whether people are aware of its reversibility is not known. Analysis of such studies may help to inform future interventions. In this review, we sought to synthesize qualitative and quantitative studies of the public's knowledge and beliefs about antibiotic resistance.
Methods

Protocol and registration
The review protocol was registered on the PROSPERO database (CRD42013005029). 
Eligibility criteria
We searched for primary studies of any study design, in any setting and published in any language that measured people's knowledge and beliefs about antibiotic resistance. Studies did not need to meet any predetermined quality criteria to be eligible. Studies that only included clinicians, did not measure knowledge or beliefs about antibiotic resistance or were published in abstract-only form were excluded.
Search and information sources
We searched MEDLINE, EMBASE, PsycINFO and CINAHL from inception until the third week of July 2014. A MEDLINE search strategy was developed and adapted for other databases (Table S1 , available as Supplementary data at JAC Online). Search terms also identified studies of clinicians' beliefs about antibiotic resistance; these studies have been reported separately. 26 We conducted forward and backward citation searching for all included articles using Web of Science and Scopus. We attempted to identify unpublished studies by contacting authors of articles available in abstract-only form and key researchers in the field.
Study selection
Two reviewers (A. R. M. and J. R. or S. P. and J. R.) independently screened titles and abstracts, followed by full texts of relevant articles. A third reviewer resolved any disagreements (C. B. D. M. or T. C. H.).
Data extraction
Two reviewers (A. R. M. and J. R. or S. P. and J. R.) independently extracted data from included studies. We contacted the author of one (Bulgarian) paper for an English translation. 27 We extracted data on study design and participants (Tables S2 and S3) .
To assess survey quality, we extracted the survey method, sampling method, response rate, sample size and description of participants. 28 For qualitative articles, we extracted the data collection method, sampling method, type of data analysis, the number of people who analysed the study transcripts and whether findings were validated by participants. 29 For knowledge and beliefs about antibiotic resistance outcomes, we extracted data from relevant fixed responses and the percentage of participants who responded affirmatively to the provided statement (yes or strongly agree/agree).
Where appropriate, we collapsed positive Likert responses (e.g. strongly agree and agree) into a single response and calculated the mean percentage of responses across the categories. For intervention studies, we extracted either the pre-intervention data (non-randomized studies) or the post-intervention control group data (randomized studies). One reviewer (A. R. M.) extracted verbatim free-text responses and qualitative outcomes. These included both direct quotes and themes identified by study authors. We treated quotes, themes and free-text data as similar and coded each, line by line, into NVivo Figure 1 summarizes the methods used for data synthesis. We synthesized quantitative data by grouping similar fixed responses into categories. We calculated the median, IQR and range of participants who agreed with that category. We explored heterogeneity within each category by: publication year (,2011 and ≥2011; 2010 was chosen as the cut-off point because it was the median publication year of included studies); continent (Europe, North America and Asia); and type of participant (parents versus non-parents).
Synthesis of results and summary measures
Data were arranged into four overarching categories that emerged from the data: knowledge of antibiotic resistance, beliefs about the importance and causes of antibiotic resistance and strategies to reduce it.
A thematic synthesis was undertaken in four stages as previously reported. 26, 30 Briefly, data were coded into themes and grouped into the four overarching categories above. Each theme was summarized and given an identifier code (e.g. I1 -4 for beliefs about importance themes one to four). Content of qualitative and qualitative themes were crossreferenced to identify common findings.
Results
We identified 54 studies, which involved a total of 55 225 participants ( Figure 1 ). Figure 2 and Tables S2 and S3 show the study characteristics. They were mainly surveys (74%); 54% had high and 34% had moderate response rates. Most studies were conducted in Europe (43%), Asia (26%) or North America (22%) (Figure 2 and Tables S2 and S3 ). In nearly all studies (50; 93%) participants were adults, some of which (11) specifically involved parents of children. Half (27; 50%) of included studies were published between 2010 and 2014.
Knowledge and beliefs about antibiotic resistance
Quantitative data
Across the eight studies that measured awareness of antibiotic resistance, a median of 70% of participants had heard of the term antibiotic resistance. Most conceptualized resistance as some change caused by antibiotics in the person to make the antibiotic ineffective (median 88%, across two studies). A median of 68% of participants, in the seven studies asking about this, believed bacteria were becoming harder to treat with antibiotics and a median of 53% of participants in four studies believed antibiotic resistance was a problem for their country (Figure 3 ) (full supporting data are in Tables S4 to S7 and five additional statements are in Table S8 ).
Most believed antibiotic resistance was due to excessive (median 70%, in 11 studies) or unnecessary (median 74%, in 8 studies) antibiotic use and not completing an antibiotic course (median 62%, in 8 studies). Less than half (median 45%, across seven studies) believed that resistance could be caused by the use of any antibiotic.
Of the few (seven) studies asking about strategies to minimize resistance, a median of 74% of participants in four studies nominated reducing antibiotic use and 84% in one study nominated discussing antibiotic resistance with their clinician. However, only a median of 36% of participants in three studies indicated they had discussed resistance with their clinician.
Heterogeneity within each category could not be explained by publication year, continent where the study took place or type of participants questioned.
Qualitative data
Findings from 13 qualitative and mixed methods studies generally supported the quantitative findings ( Figure 4 and Tables S9 to S12). Participants exhibited low awareness of antibiotic resistance (theme K1) and consistently conceived of antibiotic resistance as a change in the human body rather than in bacteria (K2).
They believed others were largely responsible for the development of antibiotic resistance (I3); perceived they had a low personal risk from resistance (I4); thought their risk increased if they were hospitalized or used prolonged courses of antibiotics Figure 2 . Summary of characteristics of included studies. Numbers denote percentage of studies. *Based on n¼24 studies with data: high¼75%-100% study response rate; moderate ¼50%-74% study response rate; low¼25%-49% study response rate; and very low¼0%-24% study response rate. Could discuss antibiotic resistance with doctor (n = 1)
Consequences of antibiotic resistance:
Bacteria are becoming harder to treat with antibiotics (n = 7) Figure 3 . Synthesis of quantitative data on public knowledge and beliefs about antibiotic resistance.
Systematic review (I4); and believed causes of resistance included antibiotic use and overuse (C1) and not completing an antibiotic course (C2). However, they believed that minimizing antibiotic resistance was outside their control and strategies should be aimed at clinicians (S1) or others' antibiotic use (S2).
Discussion
This systematic review of quantitative and qualitative studies demonstrates that the public have an incomplete understanding of and misperceptions about antibiotic resistance. Many participants also believed: they do not contribute to the development of resistance and attributed it to the actions of others; and they are at low risk from antibiotic resistance themselves. They believe the main causes of resistance are using too many antibiotics and not completing a course and that strategies to minimize resistance should largely be aimed at clinicians and other patients.
This review has a number of strengths. It used a robust search strategy and included studies of any design published in any language. Synthesis of qualitative and quantitative studies enabled more in-depth explanations of knowledge and beliefs about antibiotic resistance than would have been achieved using only quantitative data and demonstrated that findings across both qualitative and quantitative studies were similar.
This review also had a number of limitations. Of the studies for which it was possible to report a response rate (n¼ 24), the majority had a high or moderate response rate. However, many studies did not report a response rate and so the level of non-response bias may be underestimated. Much of the qualitative data were contributed by two key studies, 31, 32 whose primary aims were to explore beliefs about antibiotic resistance. Exploring knowledge and beliefs about antibiotic resistance were secondary aims in other included qualitative studies. Included studies used different data collection and analysis processes, which may also have affected data quality and subsequent analysis. We did not exclude studies based on quality and this may have affected the findings. 
Systematic review
Synthesizing the quantitative data by meta-analysis was precluded by heterogeneity in both study design and the questions posed. We are not aware of any other systematic reviews of the public's knowledge and beliefs about antibiotic resistance. We recently performed a systematic review on clinicians' knowledge and beliefs about antibiotic resistance and found some important similarities. 26 These include: clinicians' attribution of responsibility for antibiotic resistance to the actions of others; overusing antibiotics and not completing a course of them as causes of resistance; 26 and proposed strategies to reduce resistance focus on clinician behaviour rather than patient behaviour. 26 It is not surprising the public feel this way, given that they do not believe the responsibility for tackling antibiotic resistance rests with them. They trust clinicians' decisions to prescribe or withhold an antibiotic. 33, 34 In contrast, clinicians continue to perceive that most patients expect antibiotics. 35 This represents an important dissonance between the two standpoints.
The public believed that they were at low risk from resistance, although research shows that any antibiotic use can lead to resistance in individual patients. 2 This finding can be explained in two ways. Firstly, the public tend to underestimate the harms of health interventions. 36 Secondly, according to social cognitive theory, the larger the number of people that contribute to the development of a problem, and the more distant its consequences, the lower our perceived personal risk from it. 37 The belief that antibiotic overuse and not completing a course of antibiotics causes resistance form part of typical messages distributed during public health campaigns. 23 While the former is true, 2,3,38 the necessity of completing a course and its potential impact on resistance by not doing so is unclear. 39 Better evidence about the causes of antibiotic resistance is needed to resolve uncertainty here, particularly from studies that evaluate the optimal length of antibiotic courses for various indications and the effect of not completing a full course of antibiotics on resistance. 39 Some opportunities to intervene and address misperceptions have been identified by this review. The public hold an inaccurate understanding of what antibiotic resistance is and no studies explored if people know that antibiotic resistance is reversible. At a population level, public health campaigns could address these misperceptions by: providing information about how bacteria develop resistance; emphasizing that individual antibiotic use increases individuals' risk from resistance; and also by highlighting that resistance is reversible if antibiotic use is minimized. At the individual level, clinicians could use effective strategies such as shared decision making 40 (a process in which patients receive balanced, evidence-based information about benefits and harms of treatment 41, 42 ) to alert people to their actual risk of antibiotic resistance following antibiotic use and provide information on how quickly this resistance could be reversed. Current studies have not specifically asked the public about which strategies they would use to minimize resistance, but rather asked more generally what they thought would be effective. 32 Input from all stakeholders is needed when designing new interventions to minimize resistance. 43 
Conclusions
The public have heard of antibiotic resistance, but have an incomplete understanding of and misperceptions about it and its causes and do not believe they contribute to its development. These data can be used to inform the design of interventions that seek to change public beliefs about how they can contribute to tackling this global issue.
